Histone deacetylase inhibitor MPT0B291 suppresses glioma growth in vitro and in vivo partially through acetylation of p53
- Batsaikhan Buyandelger
- , Eli E. Bar
- , Kuo Sheng Hung
- , Ruei Ming Chen
- , Yung Hsiao Chiang
- , Jing Ping Liou
- , Huei Mei Huang
- , Jia Yi Wang
- Taipei Municipal Wanfang Hospital
- Graduate Institute of Medical Sciences
- TMU Research Center of Neuroscience
- Taipei Medical University Hospital
- School of Pharmacy
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- The Ph.D. Program for Translational Medicine
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine
- Master Program in Clinical Genomics and Proteomics
- TMU Research Center of Cancer Translational Medicine
- Taipei Neuroscience Institute
- International Ph.D. Program in Cell Therapy and Regenerative Medicine
- International Ph.D. Program in Medicine
Research output: Contribution to journal › Article › peer-review
26
Link opens in a new tab
Citations
(Scopus)